Serum Matrix Metalloproteinase-2: A Possible Link between COVID-19 and Periodontitis


  • Suhad Jumaa Abd-Alkareem Ministry of Health, Al-Shaab Specialized Dental Health Center, Iraq, Baghdad
  • Saad Hikmat Abdullah Ministry of Health, Al-Shaab Specialized Dental Health Center, Iraq, Baghdad
  • Noor Dhia Hasan Ministry of Health, Al-Shaab Specialized Dental Health Center, Iraq, Baghdad



Coronavirus disease-19, Periodontist, Matrix metalloproteinase 2, Inflammatory markers


Background: Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  It is a severe infection primarily targeting the respiratory system. However, many other extrapulmonary body organs are also

affected with a varying degree of severity. Some evidence indicated the development of periodontist in patients, although the pathogenesis is not well-defined.

Aims: This study aimed to investigate the association of COVID-19 severity and role of matrix metalloproteinase 2 in development of periodontitis.

Patients and Methods: This is a cross sectional study which included a total of 160 patients with COVID-19. Patients were categorized into severe and mild-moderated according to World Health Organization criteria. Periodontitis was diagnosed in those patients according to clinical criteria. Serum level of matrix metalloproteinase 2 was estimated in all patients using enzyme linked immunosorbent assay (ELISA). Demographic and laboratory data were obtained from the patients’ records.

Results: Forty-two patients (26.25%) had severe COVID-19. Demographically, older ages and the presence of comorbidities were significantly associated with COVID-19 severity. Besides the inflammatory markers, the median serum level of MMP-2 was higher in severe than mild-moderate COVID-19 cases (208.12 ng/ml vs. 196.33 ng/ml) with a significant difference. The PO rate in severe and mild-moderate COVID-19 was 23.81% and 10.17%, respectively, with a significant difference. The median serum MMP-2 in patients with PO was 228.5 ng/ml which was significantly higher than those without PO 193.81 ng/ml.

Conclusions: These data indicate the significant association between COVID-19 severity and development of PO. Matrix metalloproteinase-2 could be the possible link between severe COVID-19 and PO.


- NCPERE. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese J Epidemiol 2020. Vol. 41(2). Pp:145–151.

- Abass S. H, Abbas R. S. and Nefea L. R.T. Severity and risk of death due to COVID-19. Almustansiriyah J. Pharmaceu Sci. 2020. Vol. 20(4). Pp:1-12

- Ahmed M. A., Al-Jalleli Z. N., Alana M, A., Mostafa F. I., Al-Hamdani A. A., Faaz R., Ghanim S. M. and Al-Kataan Z. A. Two-intervention social distancing strategy to control COVID-19. Almustansiriyah J. Pharmaceu Sci. 2020. Vol. 20(13). Pp:51-57

- Yang X., Yu Y., Xu J., Shu H., Xia J., and Liu H. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020. Vol. 8(5). Pp:475–481.

- Yang Y., Shen C., Li J., Yuan J., Wei J., Huang F., Wang F., Li G., Li Y., Xing L., Peng L., Yang M., Cao M., Zheng H., Wu W., Zou R., Li D., Xu Z., Wang H., Zhang M., Zhang Z., Gao G. F., Jiang C., Liu L. and Liu Y. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J.Allergy Clin. Immunol. 2020. Vol 146(1). Pp:119–127.

- Iranmanesh B., Khalili M., Amiri R., Zartab H. and Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. Dermatol Ther. Jan 2021. Vol. 34(1). Pp: e14578.

- Seirafianpour F., Sodagar S. and Pour Mohammad A. Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review. Dermatol Ther. 2020; e13986.

- Sampson V., Kamona N. and Sampson A. Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br. Dent. J. 2020. Vol 228(12). Pp:971–975

- Gupta S., Mohindra R., Chauhan PK., Singla V., Goyal K., Sahni V., Gaur R., Verma DK., Ghosh A., Soni R. K., Suri V., Bhalla A. and Singh M. P. SARS-CoV-2 Detection in Gingival Crevicular Fluid. J. Dent. Res. 2021. Vol.100(2). Pp:187–193.

- Marouf N., Cai W., Said K. N., Daas H., Diab H., Chinta V. R., Hssain A. A., Nicolau B., Sanz M. and Tamimi F. Association between periodontitis and severity of COVID-19 infection: A case-control study. J. Clin. Periodontol. 2021. Vol.48(4). Pp:483–491

- Albaiceta G. M. and Fueyo A. Matrix metalloproteinases in acute lung injury. Berlin, Heidelberg: Springer. 2007.

- Gonzalez-Lopez A., Astudillo A., Garcıa-Prieto E., FernandezGarcıa M. S., Lopez-Vazquez A., Batalla-Solıs E., Taboada F., Fueyo A. and Albaiceta G. M. Inflammation and matrix remodeling during repair of ventilator-induced lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2011. Vol. 301(4). Pp: L500–L509.

- Liu J. and Khalil R. A. Matrix metalloproteinase inhibitors as investigational and therapeutic tools in unrestrained tissue remodeling and pathological disorders. Prog. Mol. Biol. Transl. Sci. 2017. Vol.148. Pp:355–420

- WHO. Therapeutic and COVID-19. 2021. Available at: https://apps.

- Chapple I. L. C., Mealey B. L., Van Dyke T. E., Bartold P. M., Dommisch H. and Eickholz P. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Periodontol. 2018. Vol. 89(Suppl 1). Pp: S74–S84.

- Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., Li T. and Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020. Vol.12(1). Pp: 8.

- Ambrosino I., Barbagelata E., Ortona E., Ruggieri A., Massiah G., Giannico O. V., Politi C. and Moretti A. M. I. Gender differences in patients with COVID-19: A narrative review. Monaldi Arch. Chest Dis. Arch. Monaldi per le Mal. del torace 2020. Vol. 90. Pp: 318–324.

- Jutzeler C. R., Bourguignon L., Weis C. V., Tong B., Wong C. and Rieck B. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020. Vol. 37.101825.

- Wu C., Chen X. and Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 2020. Vol. 180. Pp:934–943.

- Rostami M. and Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev. Hematol. 2020. Vol.13. Pp:1265–1275

- Gungor B., Atici A., Baycan O. F., Alici G., Ozturk F. and Tugrul S. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. Am. J. Emerg. Med. 202. Vol. 39. Pp:173–179

- Keski H. Hematological and inflammatory parameters to predict the prognosis in COVID-19. Indian J. Hematol. Blood Transfus. 2021. Vol. 37(4). Pp:1-9.

- Avila-Mesquita C., Couto A. E. S., Campos L. C. B., Vasconcelos T. F., Michelon-Barbosa J. and Corsi C. A. C. MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients. Biomed. Pharmacother. Oct 2021. Vol. 142:112067.

- Miesbach W. Pathological role of angiotensin ii in severe COVID-19. J. Thromb. Haemost. 2020. Vol. 4. Pp: e138–e144

- Hardy E. and Fernandez-Patron C. Targeting MMP-regulation of inflammation to increase metabolic tolerance to COVID19 pathologies: a hypothesis. Biomolecules 2021. Vol. 11(3). Pp390

- Takahashi Y., Watanabe N., Kamio N., Kobayashi R., Iinuma T. and Imai K. Aspiration of periodontopathic bacteria due to poor oral hygiene potentially contributes to the aggravation of COVID-19. J. Oral Sci. Dec 2020. Vol. 63(1). Pp:1-3.

- Madapusi Balaji T., Varadarajan S., Rao U. S. V., Raj A. T., Patil S., Arakeri G. and Brennan P. A. Oral cancer and periodontal disease increase the risk of COVID 19? A mechanism mediated through furin and cathepsin overexpression. Medical Hypotheses 2020. Vol. 144.109936.

- Kheur S., Kheur M., Gupta A. A. and Raj A. T. Is the gingival sulcus a potential niche for SARS-Corona virus-2? Medical Hypotheses, 2020. Vol.143.109892

- Gupta S., and Sahni V. The intriguing commonality of NETosis between COVID-19 & Periodontal disease. Medical Hypotheses 2020. Vol. 144.109968

- Sahni V. and Gupta S. COVID-19 & Periodontitis: The cytokine connection. Medical Hypotheses 2020. Vol. 144.109908.

- Patel J. and Woolley J. Necrotizing periodontal disease: Oral manifestation of COVID-19. Oral Dis. Apr 2021. Vol. 27 (Suppl 3). Pp:768-769